health biotech news today obesity drugs glp-1 The next generation of weight loss New GLP-1 Pill Foundayo (Orforglipron)

A label was updated with new safety warnings about hypersensitivity reactions and recommends infusion dosage modifications based on these infusion-related reactions

[DOI] [PubMed] [Google Scholar] 183.Deacon C.F., Pridal L., Klarskov L., Olesen M., Holst J.J

1, 2025, or on the plan sponsor's 2025 renewal date

Three GLP-1 medications will be covered under the Medicare GLP-1 Bridge Program: Who Is Eligible

Working with a team that understands the complexities of weight management - including the nutritional, behavioural, and medical aspects - can provide structure, accountability and individualised advice during the transition off medication